Luther King Capital Management (LKCM)’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,626	Closed	-$427K	–	607
2024 Q2	$427K	Sell	4,626 -348	-7%	-$30.8K	﹤0.01%	484
2024 Q1	$475K	Sell	4,974 -470	-9%	-$39.5K	﹤0.01%	474
2023 Q4	$415K	Sell	5,444 -242	-4%	-$16.8K	﹤0.01%	479
2023 Q3	$394K	Sell	5,686 -2,140	-27%	-$172K	﹤0.01%	484
2023 Q2	$738K	Sell	7,826 -1,631	-17%	-$142K	﹤0.01%	431
2023 Q1	$782K	Sell	9,457 -874	-8%	-$68.7K	﹤0.01%	415
2022 Q4	$771K	Hold	10,331	–	–	﹤0.01%	408
2022 Q3	$854K	Sell	10,331 -976	-9%	-$93.9K	0.01%	390
2022 Q2	$1.07M	Buy	11,307 +480	+4%	+$49.7K	0.01%	380
2022 Q1	$1.27M	Buy	10,827 +74	+0.7%	+$8.3K	0.01%	368
2021 Q4	$1.39M	Sell	10,753 -295	-3%	-$34.4K	0.01%	361
2021 Q3	$1.25M	Sell	11,048 -528	-5%	-$60.3K	0.01%	380
2021 Q2	$1.2M	Sell	11,576 -52	-0.4%	-$4.9K	0.01%	395
2021 Q1	$973K	Sell	11,628 -587	-5%	-$49.6K	0.01%	391
2020 Q4	$1.11M	Sell	12,215 -396	-3%	-$32.8K	0.01%	360
2020 Q3	$1.01M	Buy	12,611 +6,314	+100%	+$493K	0.01%	329
2020 Q2	$435K	Buy	6,297 +573	+10%	+$40.7K	﹤0.01%	412
2020 Q1	$360K	Sell	5,724 -4,785	-46%	-$345K	﹤0.01%	413
2019 Q4	$817K	Buy	10,509 +4,215	+67%	+$329K	0.01%	366
2019 Q3	$461K	Buy	+6,294	New	+$442K	﹤0.01%	420